Equillium, Inc. (EQ) Discusses Aryl Hydrocarbon Receptor as a Drug Target and EQ504 Program in Immune-Mediated Diseases Transcript [Seeking Alpha]
Equillium, Inc. (EQ)
Last equillium, inc. earnings: 3/26 04:07 pm
Check Earnings Report
Company Research
Source: Seeking Alpha
Company Participants Bruce Steel - Co-Founder, CEO & Director Stephen Connelly - Chief Scientific Officer & President Francisco Quintana Brian Gordon Feagan Conference Call Participants Thomas Smith - Leerink Partners LLC, Research Division Cha Cha Yang - Jefferies LLC, Research Division Raghuram Selvaraju - H.C. Wainwright & Co, LLC, Research Division Brian Feagan Catherine Novack - JonesTrading Institutional Services, LLC, Research Division Min Lee - Guggenheim Securities, LLC, Research Division Presentation Operator Good afternoon, and welcome to the Equillium Bio Virtual KOL Event. [Operator Instructions] As a reminder, this call is being recorded, and a replay will be made available on the Equillium website following the conclusion of the event. I'd now like to turn the call over to your host, Bruce Steel, Chief Executive Officer at Equillium Bio. Please go ahead, Bruce. Bruce Steel Co-Founder, CEO & Director Thank you very much. Good morning
Show less
Read more
Impact Snapshot
Event Time:
EQ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EQ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EQ alerts
High impacting Equillium, Inc. news events
Weekly update
A roundup of the hottest topics
EQ
News
- Equillium (NASDAQ:EQ) had its "sell (d-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Equillium to Participate in Upcoming Investor Conferences [Yahoo! Finance]Yahoo! Finance
- Equillium to Participate in Upcoming Investor ConferencesGlobeNewswire
- Equillium to Participate in Upcoming Investor ConferencesGlobeNewswire
- Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
EQ
Earnings
- 3/27/25 - Beat
EQ
Sec Filings
- 11/25/25 - Form 4
- 11/25/25 - Form 144
- 11/14/25 - Form SCHEDULE
- EQ's page on the SEC website